# Nitroglycerin

Drug · id `cardio:nitroglycerin` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Nitrostat; Glyceryl trinitrate

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

Nitroglycerin, sold for under-the-tongue use as Nitrostat, is a nitrate, a vasodilator (a medicine that widens blood vessels). The US label read, for Nitrostat sublingual tablets, lists the acute relief of an attack of angina pectoris, chest pain from coronary artery disease, and the acute prevention of an attack. The label says the principal action of nitroglycerin is relaxation of vascular smooth muscle. Other nitroglycerin products were not read.

## Technical summary

RxNorm ingredient 4917 (synonym glyceryl trinitrate); UNII G59M7S0WS3. MeSH descriptor D005996 is Nitroglycerin. RxClass lists the FDA chemical class Nitrates and the established pharmacologic class Nitrate Vasodilator; the record is filed under the class page Nitrates on that evidence. The label read is the Viatris Specialty LLC label for Nitrostat, application NDA021134, effective 2023-02-15 in openFDA, the label the class page already uses. The plan row pointed at a generic label (ANDA089773); the single-ingredient brand label replaces it. Nitrostat labels from repackagers and other nitroglycerin products were not read. Statements are scoped to the sublingual tablet. This page records the label indication, the product form and the mechanism sentence only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People with angina pectoris due to coronary artery disease, as described in the US label of Nitrostat sublingual tablets

Recipient: Recipient not specified; Population: Patients with angina pectoris due to coronary artery disease, for the acute relief or the acute prophylaxis of an attack, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of Nitrostat (nitroglycerin sublingual tablets, Viatris Specialty LLC, application NDA021134; the version dated 2023-02-15 in openFDA) describes the product as a stabilized sublingual compressed nitroglycerin tablet and a nitrate vasodilator. It lists the acute relief of an attack, or acute prophylaxis of an attack, of angina pectoris due to coronary artery disease.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with angina pectoris due to coronary artery disease, for the acute relief or the acute prophylaxis of an attack, as the indications section of the label states. The label passages read do not state an age range.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for the sublingual tablet only; other nitroglycerin products were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Background: openFDA drug label record for Nitrostat (nitroglycerin sublingual tablets), Viatris Specialty LLC label: indication, description, pharmacodynamics (Regulator, edition The openFDA drug label record for set id 9a52da75-d0af-4237-96c0-0b12adfa8636 (manufacturer Viatris Specialty LLC, application NDA021134), returned on 2026-11-18. The label text is dated 2023-02-15 (effective\_time). Other openFDA records of Nitrostat labels from repackagers, and labels of other nitrate products, exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229a52da75-d0af-4237-96c0-0b12adfa8636%22&limit=1>
     Locator: results\[0\].openfda.application\_number\[0\]. Retrieved 2026-11-18T20:11:52Z. Source state: Current. Version fingerprint: cae4d61c84fb7ab7ae29bb11fadbc657fd705f74cd61c6d6651902c24afdebbb.
     How it applies: Application number of the label read.
  2. Background: openFDA drug label record for Nitrostat (nitroglycerin sublingual tablets), Viatris Specialty LLC label: indication, description, pharmacodynamics (Regulator, edition The openFDA drug label record for set id 9a52da75-d0af-4237-96c0-0b12adfa8636 (manufacturer Viatris Specialty LLC, application NDA021134), returned on 2026-11-18. The label text is dated 2023-02-15 (effective\_time). Other openFDA records of Nitrostat labels from repackagers, and labels of other nitrate products, exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229a52da75-d0af-4237-96c0-0b12adfa8636%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-18T20:11:52Z. Source state: Current. Version fingerprint: cae4d61c84fb7ab7ae29bb11fadbc657fd705f74cd61c6d6651902c24afdebbb.
     How it applies: Effective date of the label text read.
  3. Supports: openFDA drug label record for Nitrostat (nitroglycerin sublingual tablets), Viatris Specialty LLC label: indication, description, pharmacodynamics (Regulator, edition The openFDA drug label record for set id 9a52da75-d0af-4237-96c0-0b12adfa8636 (manufacturer Viatris Specialty LLC, application NDA021134), returned on 2026-11-18. The label text is dated 2023-02-15 (effective\_time). Other openFDA records of Nitrostat labels from repackagers, and labels of other nitrate products, exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229a52da75-d0af-4237-96c0-0b12adfa8636%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-18T20:11:52Z. Source state: Current. Version fingerprint: cae4d61c84fb7ab7ae29bb11fadbc657fd705f74cd61c6d6651902c24afdebbb.
     How it applies: Label passage quoted in the research quote table (NIT-LB-04, NIT-LB-05).
  4. Supports: openFDA drug label record for Nitrostat (nitroglycerin sublingual tablets), Viatris Specialty LLC label: indication, description, pharmacodynamics (Regulator, edition The openFDA drug label record for set id 9a52da75-d0af-4237-96c0-0b12adfa8636 (manufacturer Viatris Specialty LLC, application NDA021134), returned on 2026-11-18. The label text is dated 2023-02-15 (effective\_time). Other openFDA records of Nitrostat labels from repackagers, and labels of other nitrate products, exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229a52da75-d0af-4237-96c0-0b12adfa8636%22&limit=1>
     Locator: results\[0\].description\[0\]. Retrieved 2026-11-18T20:11:52Z. Source state: Current. Version fingerprint: cae4d61c84fb7ab7ae29bb11fadbc657fd705f74cd61c6d6651902c24afdebbb.
     How it applies: Label passage quoted in the research quote table (NIT-LB-06).

## Connected pages

- Nitroglycerin is a nitrate vasodilator (FDA established pharmacologic class in RxClass): Nitrates (`cardio:nitrates`)
- FDA label lists the acute relief and acute prophylaxis of an attack of angina pectoris due to coronary artery disease as the indication: Angina pectoris (`cardio:angina-pectoris`) [a claim, not a settled fact; see claim `cardio:claim-fda-nitroglycerin-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Provenance

Content hash: 7542d7ab1aa64524d07335226cbe094f1e39b8230fbb720bfc09d349a45a1bf4
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
